Yamada M - Search Results

1

Neuronal mechanisms involved in drug-induced jumping behavior in mice.

Ushijima I, Mizuki Y, Yamada M, Glavin GB. Ushijima I, et al. Among authors: yamada m. Eur J Pharmacol. 1985 Jun 7;112(2):225-9. doi: 10.1016/0014-2999(85)90499-6. Eur J Pharmacol. 1985. PMID: 2992995

2

Effects of acute and long-term treatments with thyrotropin-releasing hormone on locomotor activity and jumping behavior in mice.

Ushijima I, Mizuki Y, Hara T, Watanabe K, Hirano H, Yamada M, Glavin GB. Ushijima I, et al. Among authors: yamada m. Pharmacol Biochem Behav. 1986 May;24(5):1423-8. doi: 10.1016/0091-3057(86)90205-4. Pharmacol Biochem Behav. 1986. PMID: 3088609

3

Effects of dilazep (Comelian) on the central purinergic system: inhibitory effects on clonidine-induced aggressive behavior.

Ushijima I, Mizuki Y, Hara T, Kaneyuki H, Mashimoto S, Kajimura N, Yamada M. Ushijima I, et al. Among authors: yamada m. Eur J Pharmacol. 1989 Feb 28;161(2-3):245-8. doi: 10.1016/0014-2999(89)90853-4. Eur J Pharmacol. 1989. PMID: 2721556

4

Effects of age on behavioral responses to dopamine agonists in the rat.

Ushijima I, Mizuki Y, Soeda K, Kishimoto O, Hara T, Yamada M. Ushijima I, et al. Among authors: yamada m. Eur J Pharmacol. 1987 Jun 12;138(1):101-6. doi: 10.1016/0014-2999(87)90343-8. Eur J Pharmacol. 1987. PMID: 2887433

5

Benzodiazepines increase tonic component of postdecapitation convulsions in mice.

Hara T, Ushijima I, Kawazawa S, Mizuki Y, Yamada M. Hara T, et al. Among authors: yamada m. Pharmacol Biochem Behav. 1988 Aug;30(4):1001-6. doi: 10.1016/0091-3057(88)90132-3. Pharmacol Biochem Behav. 1988. PMID: 2906433

6

Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.

Ushijima I, Mizuki Y, Imaizumi J, Yamada M, Noda Y, Yamada K, Furukawa T. Ushijima I, et al. Among authors: yamada k, yamada m. Arch Int Pharmacodyn Ther. 1985 Feb;273(2):196-201. Arch Int Pharmacodyn Ther. 1985. PMID: 4004417

7

Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.

Mizuki Y, Ushijima I, Yamada M. Mizuki Y, et al. Among authors: yamada m. Pharmacol Biochem Behav. 1996 Feb;53(2):437-40. doi: 10.1016/0091-3057(95)02014-4. Pharmacol Biochem Behav. 1996. PMID: 8808155

8

Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.

Ushijima I, Mizuki Y, Yamada M. Ushijima I, et al. Among authors: yamada m. Eur J Pharmacol. 1995 Oct 4;285(1):55-9. doi: 10.1016/0014-2999(95)00382-u. Eur J Pharmacol. 1995. PMID: 8846811

9

Dopaminergic and cholinergic interaction in cataleptic responses in mice.

Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, Yamada M. Ushijima I, et al. Among authors: yamada m. Pharmacol Biochem Behav. 1997 Sep;58(1):103-8. doi: 10.1016/s0091-3057(96)00478-9. Pharmacol Biochem Behav. 1997. PMID: 9264077

10

Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment.

Ushijima I, Mizuki Y, Yamada M. Ushijima I, et al. Among authors: yamada m. Pharmacol Biochem Behav. 1995 Feb;50(2):259-64. doi: 10.1016/0091-3057(94)00309-7. Pharmacol Biochem Behav. 1995. PMID: 7740066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,947 results

Search Page

Filters